Vardeny Orly, Gupta Deepak K, Claggett Brian, Burke Stuart, Shah Amil, Loehr Laura, Rasmussen-Torvik Laura, Selvin Elizabeth, Chang Patricia P, Aguilar David, Solomon Scott D
JACC Heart Fail. 2013 Dec;1(6):531-6. doi: 10.1016/j.jchf.2013.07.006.
This study was designed to assess the relationship between insulin resistance and incident heart failure (HF) in a community-based cohort.
Diabetes mellitus increases the risk for HF, but the association between insulin resistance and HF in individuals without diabetes is unclear.
We prospectively analyzed 12,606 participants without diabetes mellitus, prevalent HF, or history of myocardial infarction at baseline (1987 to 1989) from the ARIC (Atherosclerosis Risk in Communities) study. We assessed the relationship between insulin resistance and incident HF using the homeostatic model assessment of insulin resistance (HOMA-IR) equation, adjusting for age, sex, race, body mass index, smoking, hypertension, center, and interim myocardial infarction. We tested for interactions by age, sex, obesity, and race.
Participants with insulin resistance, defined as HOMA-IR ≥2.5 (n = 4,810, 39%), were older, more likely female, African American, hypertensive, and had a higher body mass index as compared with those without insulin resistance. There were 1,455 incident HF cases during a median of 20.6 years of follow-up. Insulin resistance defined by this threshold was not significantly associated with an increased risk for incident HF after adjustment (hazard ratio: 1.08, 95% confidence interval: 0.95 to 1.23). However, when analyzed continuously, this relationship was nonlinear, which indicated that risk increased, and was significantly associated with incident HF between HOMA-IR of 1.0 to 2.0, adjusting for baseline covariates; however, values over 2.5 were not associated with additional increased risk in adjusted models.
In a community cohort, insulin resistance, defined by lower levels of HOMA-IR than previously considered, was associated with an increased risk for HF.
本研究旨在评估基于社区的队列中胰岛素抵抗与新发心力衰竭(HF)之间的关系。
糖尿病会增加发生HF的风险,但无糖尿病个体中胰岛素抵抗与HF之间的关联尚不清楚。
我们对社区动脉粥样硬化风险(ARIC)研究中1987年至1989年基线时无糖尿病、无HF病史或心肌梗死病史的12,606名参与者进行了前瞻性分析。我们使用胰岛素抵抗稳态模型评估(HOMA-IR)方程评估胰岛素抵抗与新发HF之间的关系,并对年龄、性别、种族、体重指数、吸烟、高血压、研究中心和期间发生的心肌梗死进行了校正。我们按年龄、性别、肥胖和种族检验了交互作用。
胰岛素抵抗定义为HOMA-IR≥2.5的参与者(n = 4,810,39%)与无胰岛素抵抗的参与者相比,年龄更大,更可能为女性、非裔美国人、高血压患者,且体重指数更高。在中位20.6年的随访期间有1,455例新发HF病例。经校正后,以此阈值定义的胰岛素抵抗与新发HF风险增加无显著关联(风险比:1.08,95%置信区间:0.95至1.23)。然而,当进行连续分析时,这种关系是非线性的,这表明风险增加,并且在对基线协变量进行校正后,HOMA-IR在1.0至2.0之间时与新发HF显著相关;然而,在校正模型中,超过2.5的值与额外增加的风险无关。
在一个社区队列中,由比先前认为的更低水平的HOMA-IR定义的胰岛素抵抗与HF风险增加相关。